120 related articles for article (PubMed ID: 9923538)
21. Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines.
Ohsaki Y; Ishida S; Fujikane T; Kikuchi K
Oncology; 1996; 53(4):327-33. PubMed ID: 8692539
[TBL] [Abstract][Full Text] [Related]
22. Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells.
Min XJ; Li H; Hou SC; He W; Liu J; Hu B; Wang J
Exp Biol Med (Maywood); 2011 Apr; 236(4):483-91. PubMed ID: 21454376
[TBL] [Abstract][Full Text] [Related]
23. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
[TBL] [Abstract][Full Text] [Related]
24. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.
Takano H; Kohno K; Ono M; Uchida Y; Kuwano M
Cancer Res; 1991 Aug; 51(15):3951-7. PubMed ID: 1649696
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of etoposide after intrathoracic instillation to lung cancer patients with pleural effusion.
Wada I; Yokouchi M; Saitoh H; Takada M; Nakabayashi T; Mino K; Honma T; Takeda T; Hirano K
Int J Clin Pharmacol Ther; 1999 May; 37(5):254-9. PubMed ID: 10363625
[TBL] [Abstract][Full Text] [Related]
26. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
27. [In vitro comparison of podophyllotoxin analogues; etoposide, teniposide and NK 611 using human lung cancer cell lines].
Takigawa N; Ohnoshi T; Ueoka H; Kiura K; Moritaka T; Tabata M; Segawa Y; Shibayama T; Gemba K; Matsumura T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):473-7. PubMed ID: 8383949
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins.
Koike K; Abe T; Hisano T; Kubo T; Wada M; Kohno K; Kuwano M
Jpn J Cancer Res; 1996 Jul; 87(7):765-72. PubMed ID: 8698628
[TBL] [Abstract][Full Text] [Related]
29. Etoposide enhances the antitumor effects of cisplatin in gastric cancer cells.
Hotta T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tsunoda T; Noguchi K; Mizobata S; Arii K; Terasawa H
Anticancer Res; 1997; 17(2A):885-9. PubMed ID: 9137422
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80.
Ellis AG; Crinis NA; Webster LK
Cancer Chemother Pharmacol; 1996; 38(1):81-7. PubMed ID: 8603456
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
Némati F; Daniel C; Arvelo F; Legrier ME; Froget B; Livartowski A; Assayag F; Bourgeois Y; Poupon MF; Decaudin D
Anticancer Drugs; 2010 Jan; 21(1):25-32. PubMed ID: 19823076
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line.
Klamt F; Passos DT; Castro MA; Gelain DP; Grivicich I; Moreira JC
Toxicol In Vitro; 2008 Jun; 22(4):873-8. PubMed ID: 18282684
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.
Hong WS; Jung HY; Yang SK; Kim HR; Min YI
Anticancer Res; 1997; 17(5A):3613-6. PubMed ID: 9413212
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines.
Hong WS; Saijo N; Sasaki Y; Minato K; Nakano H; Nakagawa K; Fujiwara Y; Nomura K; Twentyman PR
Int J Cancer; 1988 Mar; 41(3):462-7. PubMed ID: 3346112
[TBL] [Abstract][Full Text] [Related]
35. [Study on the sensitization of acute myeloid leukemia cell to daunorubicin by recombinant human interleukin-3].
Wang J; Wang Q; Chen X
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):30-2. PubMed ID: 11498841
[TBL] [Abstract][Full Text] [Related]
36. Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.
Perez EA; Hack FM; Webber LM; Chou TC
Cancer Chemother Pharmacol; 1993; 33(3):245-50. PubMed ID: 8269606
[TBL] [Abstract][Full Text] [Related]
37. Different interaction of cisplatin and etoposide on in vivo and in vitro tumor systems.
Soranzo C; Pratesi G; Zunino F
Anticancer Drugs; 1990 Oct; 1(1):23-8. PubMed ID: 2131031
[TBL] [Abstract][Full Text] [Related]
38. Biological characteristics of a specific brain metastatic cell line derived from human lung adenocarcinoma.
Hu L; Zhang J; Zhu H; Min J; Feng Y; Zhang H
Med Oncol; 2010 Sep; 27(3):708-14. PubMed ID: 19669609
[TBL] [Abstract][Full Text] [Related]
39. Dipyridamole increases VP16 growth inhibition, accumulation and retention in parental and multidrug-resistant CHO cells.
Turner RN; Curtin NJ
Br J Cancer; 1996 Apr; 73(7):856-60. PubMed ID: 8611395
[TBL] [Abstract][Full Text] [Related]
40. Influence of polysorbate 80 (Tween 80) and etoposide (VP-16-213) on the pharmacokinetics and urinary excretion of adriamycin and its metabolites in cancer patients.
Cummings J; Forrest GJ; Cunningham D; Gilchrist NL; Soukop M
Cancer Chemother Pharmacol; 1986; 17(1):80-4. PubMed ID: 3698181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
